OrbiMed Genesis GP LLC - Insider Non-Derivative Transactions at Theseus Pharmaceuticals, Inc. (THRX) - (SEC)
Updated on December 12, 2024.
According to recent SEC insider information filed on Jul 17, 2023, OrbiMed Genesis GP LLC's relationship to Theseus Pharmaceuticals, Inc. (THRX) is Director,TenPercentOwner, and currently has 17,063,000 shares of Common Stock.
The chart below shows the number of shares owned, and the table shows the recent insider transactions.
You can see similar information for other THRX insiders.
Data Source: SEC.
OrbiMed Genesis GP LLC - Insider Non-Derivative Transactions at THRX
Items per page:
0 of 0
| Date | Transaction | No. of Shares | Price Per Share | Shares Owned After Transactions |
|---|---|---|---|---|
| Jul 18, 2023 | P -- (Common Stock) | 151450 | 3.05 | 650600 |
| Jul 18, 2023 | P -- (Common Stock) | 328482 | 3.05 | 17063000 |